Knott David M Jr
Long book
$168.0M
Q1 2026
Positions
85
Top-10 weight
60%
concentration
Last quarter
+16.5%
SPY +14.8%
Turnover
23%
of book per quarter
Strategy in plain words
auto-generated from filingsKnott David M Jr is a diversified fundamental manager, running a $168.0M US long book across 85 positions.
The portfolio is concentrated: the top 10 names carry 60% of the portfolio. Turnover is modest: positions are typically held for years. Current anchor positions: ALPHABET INC-CL C, APOLLO GLOBAL MANAGEMENT INC, SYNDAX PHARMACEUTICALS INC, BRIDGEBIO PHARMA INC, PROTAGONIST THERAPEUTICS INC.
Over the last 9 quarters its long book ran on average 2.3pp per quarter ahead of the S&P 500, beating the index in 6 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
+3.8%
Q2 2024
+6.1%
Q3 2024
+11.2%
Q4 2024
-19.4%
Q1 2025
+5.3%
Q2 2025
+13.4%
Q3 2025
+14.8%
Q4 2025
+9.5%
Q1 2026
+16.5%
Sector allocation
Healthcare 55%
Financials 24%
Technology 18%
Other 2%
Energy 1%
Industrials 0%
Consumer staples 0%
Materials 0%
Long book by quarter
What does Knott David own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| GOOG ALPHABET INC-CL C | Technology | 91.4K | $26.2M | 15.6% | Held |
| APO APOLLO GLOBAL MANAGEMENT INC | Financials | 225.0K | $25.1M | 14.9% | Held |
| SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 422.0K | $9.9M | 5.9% | +1.7% |
| BBIO BRIDGEBIO PHARMA INC | Healthcare | 90.0K | $6.7M | 4.0% | +5.9% |
| PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 63.0K | $6.6M | 4.0% | -13.7% |
| XERS XERIS BIOPHARMA HOLDINGS INC | Healthcare | 1.1M | $6.1M | 3.7% | +9.3% |
| JPM JPMORGAN CHASE & CO | Financials | 19.5K | $5.7M | 3.4% | Held |
| IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 1.6M | $5.6M | 3.3% | New |
| LPLA LPL Financial Holdings Inc. | Financials | 16.5K | $5.0M | 3.0% | New |
| ALKS ALKERMES PLC | Healthcare | 120.0K | $4.2M | 2.5% | +26.3% |
| TVTX TRAVERE THERAPEUTICS INC | Healthcare | 140.6K | $4.2M | 2.5% | -24.4% |
| COGT COGENT BIOSCIENCES INC | Healthcare | 104.0K | $4.0M | 2.4% | +2.0% |
| VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 181.0K | $3.5M | 2.1% | +24.8% |
| AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 93.1K | $3.1M | 1.9% | +417.0% |
| RLMD RELMADA THERAPEUTICS INC | Healthcare | 439.3K | $3.1M | 1.8% | New |
| TGTX TG THERAPEUTICS INC | Healthcare | 90.0K | $3.0M | 1.8% | +100.0% |
| CPRX CATALYST PHARMACEUTICALS INC | Healthcare | 120.0K | $3.0M | 1.8% | -36.5% |
| ACLXGBX ARCELLX INC | — | 19.4K | $2.2M | 1.3% | -24.4% |
| AB ALLIANCEBERNSTEIN HOLDING LP | Financials | 48.0K | $1.8M | 1.1% | Held |
| RCUS ARCUS BIOSCIENCES INC | Healthcare | 81.2K | $1.8M | 1.0% | -33.0% |
| DCGO DOCGO INC | Healthcare | 2.7M | $1.7M | 1.0% | Held |
| HELP CYBIN INC | Healthcare | 350.0K | $1.7M | 1.0% | +22.7% |
| CYTK CYTOKINETICS INC | Healthcare | 23.6K | $1.6M | 0.9% | -30.5% |
| ATRC ATRICURE INC | Healthcare | 51.4K | $1.5M | 0.9% | Held |
| ARDX ARDELYX INC | Healthcare | 207.0K | $1.2M | 0.7% | New |
| JNJ JOHNSON & JOHNSON | Healthcare | 4.9K | $1.2M | 0.7% | -28.9% |
| RZLT REZOLUTE INC | Healthcare | 370.0K | $1.1M | 0.7% | +8.8% |
| OBIO ORCHESTRA BIOMED HOLDINGS IN | Healthcare | 253.7K | $1.1M | 0.6% | +1.5% |
| MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 2.0K | $1.0M | 0.6% | Held |
| VERA VERA THERAPEUTICS INC | Healthcare | 26.0K | $1.0M | 0.6% | Held |
| CNTB CONNECT BIOPHARMA HOLDINGS L | Healthcare | 387.8K | $1.0M | 0.6% | +93.9% |
| PFE PFIZER INC | Healthcare | 32.3K | $908K | 0.5% | Held |
| BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 13.6K | $826K | 0.5% | -38.1% |
| CNQ CANADIAN NATURAL RESOURCES | Energy | 16.8K | $819K | 0.5% | Held |
| BIIB BIOGEN INC | Healthcare | 4.0K | $733K | 0.4% | -33.3% |
| RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 33.1K | $693K | 0.4% | +65.3% |
| AAPL APPLE INC | Technology | 2.5K | $633K | 0.4% | Held |
| MSFT MICROSOFT CORP | Technology | 1.6K | $592K | 0.4% | Held |
| VSTM VERASTEM INC | Healthcare | 104.0K | $551K | 0.3% | New |
| ADMA ADMA BIOLOGICS INC | Healthcare | 60.2K | $542K | 0.3% | Held |
| IBM INTL BUSINESS MACHINES CORP | Technology | 2.1K | $519K | 0.3% | Held |
| PTHS PELTHOS THERAPEUTICS INC | Healthcare | 21.1K | $443K | 0.3% | +9.3% |
| KURA KURA ONCOLOGY INC | Healthcare | 52.8K | $429K | 0.3% | +34.6% |
| EOLS EVOLUS INC | Healthcare | 99.3K | $408K | 0.2% | Held |
| CGEM CULLINAN THERAPEUTICS INC | Healthcare | 24.2K | $344K | 0.2% | New |
| SLDB SOLID BIOSCIENCES INC | Healthcare | 47.1K | $339K | 0.2% | -71.0% |
| LENZ LENZ THERAPEUTICS INC | Healthcare | 33.7K | $309K | 0.2% | -37.2% |
| WVE WAVE LIFE SCIENCES LTD | Healthcare | 40.0K | $290K | 0.2% | -55.6% |
| RAIN RAIN ENHANCEMENT TECHNO-CL A | Industrials | 101.7K | $258K | 0.2% | New |
| KMB KIMBERLY-CLARK CORP | Other | 2.4K | $232K | 0.1% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 14, 2026 | 88 | $168.0M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 12, 2026 | 91 | $215.9M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 12, 2025 | 92 | $248.0M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 11, 2025 | 89 | $220.6M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 12, 2025 | 88 | $212.0M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 12, 2025 | 93 | $276.5M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 13, 2024 | 99 | $284.6M | $K fixed canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 12, 2024 | 106 | $250.6M | $K fixed canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 14, 2024 | 114 | $282.8M | $K fixed canonical | SEC ↗ |
Similar funds
DIAMANT ASSET MANAGEMENT, INC. LILLY ENDOWMENT INCBROOKFIELD Corp /ON/GQG Partners LLCMITSUBISHI UFJ FINANCIAL GROUP INCNewport Trust Company, LLCVIKING GLOBAL INVESTORS LPPARNASSUS INVESTMENTS, LLC MASTERCARD FOUNDATION ASSET MANAGEMENT CORPPZENA INVESTMENT MANAGEMENT LLCCOATUE MANAGEMENT LLCWinslow Capital Management, LLC